Insider trades appear within seconds, the rest within the hour.

Get alerts

← Feed

IMMXNasdaq

Immix Biopharma, Inc.

Alert me on IMMX
0
Insider buys, 6 months
0
Congress trades, 6 months
0
Signals, 6 months

Six months

After each filing

4
Dec 11, 2025 Buy Rachman Ilya M Insider
1 week
−22.6%S&P −1.8%
1 month
−38.8%S&P +1.0%
3 months
+45.9%S&P −2.6%
6 months
+14.8%S&P +10.2%
Dec 11, 2025 Buy Morris Gabriel S Insider
1 week
−22.6%S&P −1.8%
1 month
−38.8%S&P +1.0%
3 months
+45.9%S&P −2.6%
6 months
+14.8%S&P +10.2%
Sep 18, 2025 Buy Rachman Ilya M Insider
1 week
−2.4%S&P −0.4%
1 month
+37.3%S&P +0.6%
3 months
+166.0%S&P +1.7%
6 months
+335.9%S&P −1.2%
Sep 18, 2025 Buy Morris Gabriel S Insider
1 week
−2.4%S&P −0.4%
1 month
+37.3%S&P +0.6%
3 months
+166.0%S&P +1.7%
6 months
+335.9%S&P −1.2%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for IMMX

23 held · newest 523 held · newest 2
Loading the filings.
See all 23 filings for IMMX

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal
No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters
NoneQ4 2025
$70KQ1 2026
$145KQ2 2026
$245KQ3 2026
Up 69 percent from Q2 2026. Reported to the Senate each quarter by the firms it hires.Original report ↗

Read from LDA.gov between Sep 23, 2026 and Oct 21, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.